Sugi Predict

Sugi Predict / Compounds / SCHEMBL710887

SCHEMBL710887

SCHEMBL710887

CCOC(=O)C(CC)(CC)CP(=O)(O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 2/20 0.50
▸ CYP4A11 Q02928 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.36
▸ PKM P14618 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ALOX15 P16050 1/20 0.33
▸ MGAM O43451 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ SI P14410 1/20 0.33
▸ MGAM2 Q2M2H8 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SOAT1 P35610 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2238644 0.85 CYP4F2 (0.43) CYP4F2CYP4A11ALDH1A1PKMKDM4E
SCHEMBL2238383 0.85 CYP4F2 (0.36) CYP4F2CYP4A11ALDH1A1LMNA
SCHEMBL2240467 0.82 CYP4F2 (0.49) CYP4F2CYP4A11PKMMEN1KMT2A
SCHEMBL2239056 0.82 CYP4F2 (0.38) CYP4F2CYP4A11ALDH1A1PKMKDM4E
SCHEMBL2242249 0.82 ALDH1A1 (0.42) CYP4F2CYP4A11ALDH1A1
SCHEMBL1691821 0.82 MMP1 (0.32) CYP4F2CYP4A11ALDH1A1MMP8
SCHEMBL2052355 0.81 CYP4F2 (0.56) CYP4F2CYP4A11ALDH1A1PKMKDM4E
SCHEMBL444076 0.80 CYP4F2 (0.63) CYP4F2CYP4A11ALDH1A1PKMKDM4E
SCHEMBL2350137 0.79 LPAR3 (0.49) —
SCHEMBL2350508 0.79 LPAR3 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101023116-B Polytrimethylene terephthalate with low acrolein content and process for producing the same LURGI ZIMMER GMBH 2013-08-14 — — CN claimed
CN-101023116-A Polytrimethylene terephthalate with low acrolein content and process for producing the same SHELL INT RESEARCH (NL) 2007-08-22 — — CN claimed
JP-60152556-A — — None — — JP disclosed
CN-120895758-A Electrolyte with phosphonate as organic additive and water-based zinc ion battery 中国科学院福建物质结构研究所 2025-11-04 — — CN disclosed
US-12404247-B2 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2025-09-02 — — US disclosed
EP-4527464-A2 NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME Mitsubishi Tanabe Pharma Corporation (JP) 2025-03-26 — — EP disclosed
EP-4219452-B1 NOVEL 3,5-DISUBSTITUTED PYRIDINE AND 3,5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME MITSUBISHI TANABE PHARMA CORP (JP) 2025-01-01 — — EP disclosed
US-12159967-B2 Nonaqueous electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-12-03 — — US disclosed
US-20240239756-A1 NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME MITSUBISHI TANABE PHARMA CORPORATION (JP) 2024-07-18 — — US disclosed
US-20240128511-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-04-18 — — US disclosed
US-11958812-B2 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2024-04-16 — — US disclosed
US-6011039-A USEFUL AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS; TREATING HYPERPHAGIA, OBESITY OR DIABETES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-01-04 — — US disclosed
EP-0889034-A1 AMINOPYRIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-01-07 — — EP disclosed
WO-1996019484-A1 NOVEL CARBOXAMIDE-DERIVED PHOSPHONATES, METHOD FOR MAKING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID PHOSPHONATES PIERRE FABRE MEDICAMENT (FR) 1996-06-27 — — WO disclosed
US-5514292-A FOR USE WITH REFRIGERANTS, EPOXY CONTAINING PHOSPHONATE TONEN CORPORATION (JP) 1996-05-07 — — US disclosed
EP-0640681-A1 Lubricating oil composition Tonen Corporation (JP) 1995-03-01 — — EP disclosed
US-5366646-A Epoxide, phosphate, benzotriazole TONEN CORPORATION (JP) 1994-11-22 — — US disclosed
EP-0568038-A2 Lubricating oil composition Tonen Corporation (JP) 1993-11-03 — — EP disclosed
JP-S60152556-A FLAME PROOF POLYESTER COMPOSITION NIPPON ESTER CO LTD 1985-08-10 — — JP disclosed
US-4278791-A CORROSION RESISTANCE, WETTING AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1981-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404247-B2 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same ENPP2, PGA5, PLPBP CYP4F2 445/4885CYP4A11 861/4885ALDH1A1 2426/4885
US-20240239756-A1 NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME ENPP2, SSB, PLPBP CYP4F2 399/4885CYP4A11 624/4885ALDH1A1 2904/4885
US-11958812-B2 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same ATXN2, ATXN10, ARSA CYP4F2 1452/4885CYP4A11 1393/4885ALDH1A1 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.